Page 83 - Škrgat, Sabina, ed. 2023. Severe Asthma Forum - Monitoring and Treatable Traits in Severe Asthma. Koper: University of Primorska Press. Severe Asthma Forum, 2
P. 83
ex
A L
allergic bronchopulmonary aspergillosis 41, language therapy 13
42
allergic fungal airway disease 41, 42 M
alternative overlap syndrome 47, 48, 49
asthma phenotypes 55 maneuvers 13, 18
B O
biologics 63, 64, 65, 66, 67, 68, 69, 70, 71, obstructive sleep apnea 47, 77
72 OSA 47, 48, 49, 50
blood eosinophilia 43, 55
P
D
pulmonary function tests 23
dysfunctional breathing 23, 24, 25, 26, 32
dyspnea 13, 14, 16, 18, 19, 20, 55, 56, 59 S
E safety 55, 59, 63, 65, 68, 70, 71
severe asthma 28, 30, 33, 41, 42, 43, 44, 47,
evaluation 16, 28, 63, 67 48, 50, 55, 56, 57, 58, 59, 63, 64, 65, 66, 67,
68, 69, 70, 71
F speech 13, 17, 18, 19, 20
sputum eosinophilia 55
fungal bronchitis 42, 44 sputum induction 55, 56, 59
H T
hyperventilation 14, 23, 24, 25, 26, 27, 28, T2 high asthma 63, 71
29, 30, 31, 32, 33 T2 low asthma 69
therapeutic response 63, 64, 65, 66, 67, 68,
I 69, 71, 72
IgE sensibilisation 41 V
vocal cords dysfunction 13
A L
allergic bronchopulmonary aspergillosis 41, language therapy 13
42
allergic fungal airway disease 41, 42 M
alternative overlap syndrome 47, 48, 49
asthma phenotypes 55 maneuvers 13, 18
B O
biologics 63, 64, 65, 66, 67, 68, 69, 70, 71, obstructive sleep apnea 47, 77
72 OSA 47, 48, 49, 50
blood eosinophilia 43, 55
P
D
pulmonary function tests 23
dysfunctional breathing 23, 24, 25, 26, 32
dyspnea 13, 14, 16, 18, 19, 20, 55, 56, 59 S
E safety 55, 59, 63, 65, 68, 70, 71
severe asthma 28, 30, 33, 41, 42, 43, 44, 47,
evaluation 16, 28, 63, 67 48, 50, 55, 56, 57, 58, 59, 63, 64, 65, 66, 67,
68, 69, 70, 71
F speech 13, 17, 18, 19, 20
sputum eosinophilia 55
fungal bronchitis 42, 44 sputum induction 55, 56, 59
H T
hyperventilation 14, 23, 24, 25, 26, 27, 28, T2 high asthma 63, 71
29, 30, 31, 32, 33 T2 low asthma 69
therapeutic response 63, 64, 65, 66, 67, 68,
I 69, 71, 72
IgE sensibilisation 41 V
vocal cords dysfunction 13
